ArticleAmerican journal of preventive cardiology2026
Impact of incretin therapies on biochemical and imaging outcomes in metabolic dysfunction-associated steatotic liver disease.
Nicole Ann Tesoro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.